Previous Close | 1.3100 |
Open | 1.3300 |
Bid | 0.0000 x 800 |
Ask | 0.0000 x 800 |
Day's Range | 1.1400 - 1.3300 |
52 Week Range | 0.9210 - 35.5000 |
Volume | |
Avg. Volume | 1,180,581 |
Market Cap | 2.019M |
Beta (5Y Monthly) | 0.96 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.3740 |
Earnings Date | May 11, 2023 - May 15, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 20.00 |
Supports the therapeutic potential of rare cannabinoids in inflammatory skin conditions such as atopic dermatitis, psoriasis, pruritus, and acneFurther demonstrates the anti-inflammatory effects of CBC, THCV, CBG and CBGADetails possible mechanisms of action on how rare cannabinoids can interact with specific skin-related endocannabinoid receptorsVancouver, British Columbia--(Newsfile Corp. - March 13, 2023) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a leader in the p
Company Executives Share Vision and Answer Questions at VirtualInvestorConferences.comNEW YORK, March 10, 2023 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the Life Sciences Virtual Investor Forum held on March 9th are now available for online viewing. REGISTER NOW AT: https://bit.ly/3kZM24S The company presentations will be available 24/7 for 90 days. Investors, advisors, and analysts may download in
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.comNEW YORK, March 07, 2023 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the agenda for the Life Sciences Virtual Investor Forum to be held March 9th. Individual investors, institutional investors, advisors, and analysts are invited to attend. REGISTER NOW AT: https://tinyurl.com/0323LSIFVIC It is recommended that investors pre-register